Clinical Trial: To analyze the risk factors of early leukopenia in patients with Graves' disease treated with methimazole and to construct and validate a nomogram prediction model (China)

Posted On: 2026-09-29

China, Sept. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'To analyze the risk factors of early leukopenia in patients with Graves' disease treated with methimazole and to construct and validate a nomogram prediction model'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133496

Registration Time: 2026/09/28

Type: Observational study

Primary Sponsor: The First People’s Hospital of Jingzhou

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341966

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: To analyze the risk factors of early leukopenia in patients with Graves' disease treated with methimazole and to construct and validate a nomogram prediction model (China)